AstraZeneca’s hypertension pill scores second late-stage winnews2025-10-07T09:25:13+00:00October 7th, 2025|Endpoints News|
Mary Brunkow, Fred Ramsdell, Shimon Sakaguchi win Nobel for Treg cell findingsnews2025-10-06T15:22:20+00:00October 6th, 2025|Endpoints News|
Abivax releases more data from major Phase 3 wins in ulcerative colitisnews2025-10-06T14:45:28+00:00October 6th, 2025|Endpoints News|
Skye’s cannabinoid drug fails in mid-stage obesity trialnews2025-10-06T11:00:10+00:00October 6th, 2025|Endpoints News|
AstraZeneca, Daiichi Sankyo report Phase 3 win for Datroway in triple negative breast cancernews2025-10-06T10:14:51+00:00October 6th, 2025|Endpoints News|
Trogenix raises $95M Series A as brain cancer program nears clinicnews2025-10-05T23:01:22+00:00October 5th, 2025|Endpoints News|
Rocket withdraws FDA application for rare blood disorder gene therapynews2025-10-03T14:56:01+00:00October 3rd, 2025|Endpoints News|
Ovid gets a boost from Phase 1 data, $81M+ PIPE financingnews2025-10-03T13:52:25+00:00October 3rd, 2025|Endpoints News|
Amgen’s cholesterol-lowering shot could get sales boost from CV trial successnews2025-10-02T13:00:40+00:00October 2nd, 2025|Endpoints News|
Takeda lays off 137 workers following cell therapy stoppagenews2025-10-02T08:54:55+00:00October 2nd, 2025|Endpoints News|
